Diagnosis: From neuropathology to neuroimagery;Le diagnostic: De la neuropathologie à l'imagerie cérébrale

Medecine/Sciences

Volumn 18, Issue 6-7, 2002, Pages 697-708

  Dhenain, Marc ^a   Lehéricy, Stéphane ^a   Duyckaerts, Charles ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN PERFUSION; DISEASE COURSE; DISEASE SEVERITY; GLUCOSE METABOLISM; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0036314109     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20021867697     Document Type: Review

References (59)

1. Alzheimer disease
2. Fiber disorganization in the neocortex of patients with senile dementia of the Alzheimer type
3. Paired helical filaments are twisted ribbons composed of two parallel and aligned components: Image reconstruction and modeling of filament structure using atomic force microscopy
4. Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer
5. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins
6. Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging
7. Subtypes and differential laminar distributions of βA4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases
8. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases
9. Neuritic plaques in senile dementia of the Alzheimer type: A Golgi analysis in the hippocampal region
10. Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: Relationship with the intellectual status in 29 cases
11. Inflammation and Alzheimer's disease: Relationships between pathogenic mechanisms and clinical expression
12. Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease
13. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
14. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease
15. Activation of caspase-3 in single neurons and autophagic granules of granulavacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death
16. Synapse loss in the temporal lobe in Alzheimer's disease
17. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease
18. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
19. Correlations of synaptic and pathological markers with cognition of the elderly
20. Large amounts of neocortical βA4 deposits without Alzheimer changes in a nondemented case
21. Cerebral amyloid deposition and diffuse plaques in « normal » aging: Evidence for presymptomatic and very mild Alzheimer's disease
22. An 'anatomical cascade hypothesis' for Alzheimer's disease
23. Prevalence, incidence and duration of Brook's stages in the general population: Can we know?
24. Evolution of neuronal changes in the course of Alzheimer's disease
25. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
26. Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy
27. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy
28. Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images
29. MR microimaging of contrast tagged amyloid plaques in transgenic mouse models of Alzheimer's disease
30. Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Aβ peptide radiopharmaceutical
31. Ageing and dementia
32. Regional weight loss in the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type
33. Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length
34. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
35. A quantitative study of cerebral atrophy in old age and senile dementia
36. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzeimer's disease
37. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
38. Memory disorders in probable Alzheimer's disease: The role of hippocampal atrophy as shown with MRI
39. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies: A comparison with Alzheimer's disease, vascular dementia and normal ageing
40. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease
41. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images
42. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease
43. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease
44. Mild cognitive impairment and Alzheimer disease: Regional diffusivity of water
45. Probable Alzheimer's disease. Diagnosis with proton MR spectroscopy
46. Magnetic resonance spectroscopic changes in Alzheimer's disease
47. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping
48. Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease
49. The use of SPECT in a multidisciplinary memory clinic
50. Early diagnosis of Alzheimer disease with positron emission tomography
51. Brain imaging and age-related changes in cognition
52. Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation
53. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease
54. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease
55. Central nervous system disorders in aging
56. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits
57. Imaging brain cholinergic activity with positron emission tomography: Its role in the evaluation of cholinergic treatments in Alzheimer's dementia
58. Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging
59. Modeling the relation between neurofibrillary tangles and intellectual status